Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Athletic Heart Syndrome


Basics


Description


  • Sustained exercise training induces adaptive changes in the cardiovascular system that allow for greater athletic performance. The major adaptations involve the heart, blood, and peripheral vascular system.
  • Heart:
    • Cardiac hypertrophy that is eccentric with predominant isotonic exercise and concentric with predominant isometric exercise
    • Resting sinus bradycardia
  • Blood:
    • Total blood volume increases due to proportional increases in red cells and plasma.
  • Peripheral vascular system:
    • Peripheral vascular capacitance increases, resulting in relative decreases in peripheral vascular resistance, allowing movement of a greater stroke volume without increases in systolic pressure.
  • Systems affected:
    • Cardiovascular
    • Hematopoietic

Epidemiology


  • Predominant age: Late adolescence to middle aged
  • Predominant Sex: Male > Female
  • Age-related factors:
    • Pediatric: Congenital heart disease predominates
    • Middle-aged: Coronary artery disease dominates

Incidence
Sudden death in athletes is rare.  
Prevalence
Heart disease in accomplished athletes is unusual.  

Risk Factors


Underlying heart disease.  
Genetics
  • Adaptations to exercise and athletic ability may be partially determined by heredity.
  • Inherited heart disease more common in younger athletes.

General Prevention


  • Exercise training does not eliminate heart disease. Risk-factor control is still necessary to avoid coronary artery disease.
  • Physical fitness improves survival in heart disease.

Pathophysiology


  • The ability to increase cardiac output largely determines exercise ability.
  • LV hypertrophy is expected and often other cardiac chambers enlarge.
  • Vagal nerve tone increases such that resting bradycardia is common.

Etiology


Regular, vigorous exercise training.  

Associated Conditions


  • Cardiac hypertrophy
  • Resting bradycardia
  • Increased skeletal muscle mass

Diagnosis


History


  • History of athletic training and prowess
  • Orthostatic symptoms

Physical Exam


  • Athletic physique
  • Sinus bradycardia
  • Sinus arrhythmia
  • Enlarged apical impulse
  • RV lift
  • Diastolic gallop sounds
  • Systolic flow murmurs

Tests


Lab
  • EKG: Ventricular hypertrophy patterns (may mimic MI), bradyarrhythmias
  • Exercise: Maximum oxygen uptake will identify exercise-trained individuals.

Imaging
  • CXR: Cardiac enlargement
  • Echo: Distinguish physiologic vs. pathologic ventricular hypertrophy; identify valvular disease, cardiomyopathy and congenital heart disease.

Surgery
  • If coronary artery disease is suspected, exercise testing with echo or radionuclide imaging may be indicated, or in some cases coronary angiography.
  • Electrophysiologic testing may be required to distinguish pathologic rhythm disturbances from benign ones.
  • Tilt table testing may help elucidate the cause of dizziness or syncope encountered in an athlete.

Pathological Findings
Ventricular hypertrophy  

Differential Diagnosis


  • Abnormal bradyarrhythmias
  • Pathologic ventricular hypertrophy
  • Valvular heart disease
  • Cardiomyopathy
  • Coronary artery disease

Treatment


Medication


  • Depends on specific underlying heart disease if any
  • Significant possible interactions and adverse reactions:
    • Refer to manufacturer's literature.
    • Some performance-enhancing drugs have potential adverse effects on the heart, such as anabolic steroids and catecholamines.
  • Contraindications:
    • Refer to manufacturer's profile of each drug.
  • Precautions:
    • Athletically trained individuals are especially susceptible to drugs with vasodilator or heart rate-slowing properties such as α and β-blockers.

Additional Treatment


General Measures
  • Outpatient evaluation
  • Distinguish normal physiologic changes from disease
  • Many cardiac diseases increase the risk of athletic activity:
    • Hypertrophic cardiomyopathy
    • Coronary artery anomalies or disease
    • Marfan syndrome
    • Aortic valve disease
    • Complex congenital heart disease
    • Pulmonary HTN
    • Mitral stenosis
    • Pulmonic stenosis

Issues for Referral
Suspected cardiac disease in an athlete  
Additional Therapies
  • Occasionally athletic training will need to be stopped temporarily until a specific disease is treated with drugs that affect a response in the patient.
  • Mega-dose vitamins
  • Creatine

Surgery


Corrective surgery for cardiac conditions may permit athletic activity.  

In-Patient Considerations


Initial-Stabilization
Treat cardiac arrhythmias  
Admission Criteria
  • Cardiac arrest
  • Heart failure
  • Severe chest pain
  • Syncope

IV Fluids
Use with electrolyte replacement to treat dehydration  
Nursing
Continuous ECG monitoring  
Discharge Criteria
  • Absence of arrhythmias
  • Primary disease identified and steps taken to stabilize and positively correct

Ongoing Care


Follow-Up Recommendations


Depends on the cardiac condition  
Patient Monitoring
Occasionally the only way to distinguish normal physiology from disease is to cease exercise training and observe the patient. Sinus bradycardia and chamber enlargement usually regress significantly within weeks.  

Diet


Depends on cardiac conditions and training requirements.  

Patient Education


Important to describe risks of cardiac disease if patient desires participation in athletic activities.  

Prognosis


  • Exercise-trained individuals are usually healthier and live longer than sedentary individuals in the absence of significant cardiovascular disease.
  • The combination of athletic activities and certain cardiovascular diseases can shorten life.

Complications


  • Aortic dissection
  • Precipitation of heart failure
  • Sudden arrhythmic death
  • Syncope

Additional Reading


1Corrado  D, Basso  C, Pavei  A. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA.  2006;296:1593-1601.  [View Abstract]2Maron  BJ, Zipes  DP. 36th Bethesda conference: Eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol.  2005;45:1312-1375.3Maron  BJ, Haas  TS, Doerer  JJ. Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies. Am J Cardiol.  2009;104:276-280.  [View Abstract]4Maron  BJ, Doerer  JJ, Haas  TS. Sudden deaths in young competitive athletes: Analysis of 1866 deaths in the United States, 1980-2006. Circulation.  2009;119:1085-1092.  [View Abstract]5Pelliccia  A, Di Paolo  FM, Quattrini  FM. Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med.  2008;358:152-161.  [View Abstract]6H Maron  BJ. Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification. Cardiol Clin.  2007;25:399-414.

Codes


ICD9


429.3 Cardiomegaly  

SNOMED


233931008 athlete's heart (disorder)  

Clinical Pearls


  • Physiologic adaptations to exercise training can mimic cardiac disease.
  • Cardiac hypertrophy and resting bradycardia are the hallmarks of athletic training.
  • Underlying heart disease can lead to symptoms or sudden death.
  • Screening young athletes for heart disease can save lives, but may lead to a recommendation to cease athletic activities.
Copyright © 2016 - 2017
Doctor123.org | Disclaimer